AD-1161

DRUG3 trials

Sponsors

Addpharma Inc.

Conditions

Benign Prostatic Hyperplasia

Phase 1

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

CompletedNCT07103278

Addpharma Inc.Benign Prostatic Hyperplasia

Start: 2026-01-22End: 2026-03-07Updated: 2026-07-28

A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

Not yet recruitingNCT07715305

Addpharma Inc.Benign Prostatic Hyperplasia

Start: 2026-07-01End: 2026-08-01Target: 44Updated: 2026-07-20

A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Not yet recruitingNCT07722871

Addpharma Inc.Benign Prostatic Hyperplasia

Start: 2026-07-01End: 2026-10-01Target: 44Updated: 2026-07-27